Literature DB >> 17299252

Residual late radiation damage in mouse stromal tissue assessed by the tumor bed effect.

Jaap Haveman1, Hans Rodermond, Chris van Bree, Jan Wondergem, Nicolaas A P Franken.   

Abstract

Irradiation of murine subcutaneous stroma before implantation of tumor cells leads to retarded tumor growth. This effect is called Tumor Bed Effect (TBE) and can be used to assess the sensitivity of stromal tissue to radiation. We tested the ability of stromal tissue to recover from X-ray-induced damage as a function of the time interval between X-irradiation and implantation of tumor cells over a period of 195 days. We also assessed the effects of a second test treatment of X-irradiation before implantation to assess residual damage by the first radiation treatment. The tumor bed effect in C57Bl10xDBA2 mice observed after X-ray treatment and implantation of M8013 cells (from a transplantable mouse mammary carcinoma) declines with the time that elapses between X-rays and implantation. Implantation of tumor cells 195 days after initial irradiation of 10 or 20 Gy resulted in a considerably smaller TBE. The half-time of the decay is estimated as about 50 days. The extent of the recovery was then tested in two-fraction experiments, with radiation fractions separated by intervals of 30 or 180 days. In the experiment with re-irradiation at an interval of 30 days after the first radiation dose of 20 Gy hardly any recovery was observed, whereas at an interval of 180 days a considerable recovery was observed. We presume that the recovery in TBE that was observed a long time after the irradiation results from a proliferative stimulus to endothelial cells which takes place during the post-irradiation period. The proliferative response leads to cell death of the X-ray damaged endothelial cells and thereafter these are replaced by healthy cells.

Entities:  

Mesh:

Year:  2007        PMID: 17299252     DOI: 10.1269/jrr.0631

Source DB:  PubMed          Journal:  J Radiat Res        ISSN: 0449-3060            Impact factor:   2.724


  6 in total

1.  Tumour bed irradiation of human tumour xenografts in a nude rat model using a common X-ray tube.

Authors:  S V Tokalov; W Enghardt; N Abolmaali
Journal:  J Biosci       Date:  2010-06       Impact factor: 1.826

2.  Recurrence and mortality according to estrogen receptor status for breast cancer patients undergoing conservative surgery. Ipsilateral breast tumour recurrence dynamics provides clues for tumour biology within the residual breast.

Authors:  Romano Demicheli; Ilaria Ardoino; Patrizia Boracchi; Danila Coradini; Roberto Agresti; Cristina Ferraris; Massimiliano Gennaro; William J M Hrushesky; Elia Biganzoli
Journal:  BMC Cancer       Date:  2010-11-30       Impact factor: 4.430

3.  Adhesion molecule expression and function of primary endothelial cells in benign and malignant tissues correlates with proliferation.

Authors:  Wolfgang Sievert; Soile Tapio; Stephanie Breuninger; Udo Gaipl; Nicolaus Andratschke; Klaus-Rüdiger Trott; Gabriele Multhoff
Journal:  PLoS One       Date:  2014-03-14       Impact factor: 3.240

4.  Hemostatic Effect of Palliative Radiation Therapy in Preventing Blood Transfusions from Bleeding Occurring within Advanced Gastric Cancer.

Authors:  Norio Mitsuhashi; Hajime Ikeda; Yoshitaka Nemoto; Mayumi Kuronuma; Masahiro Kamiga; Yoshinori Hiroshima
Journal:  Palliat Med Rep       Date:  2021-12-22

5.  [68Ga]FAPI-PET/CT for radiation therapy planning in biliary tract, pancreatic ductal adeno-, and adenoidcystic carcinomas.

Authors:  Nika Guberina; Lukas Kessler; Christoph Pöttgen; Maja Guberina; Martin Metzenmacher; Ken Herrmann; Maja Mucha; Christoph Rischpler; Frank Indenkämpen; Jens T Siveke; Jürgen Treckmann; Lale Umutlu; Stefan Kasper; Wolfgang P Fendler; Martin Stuschke
Journal:  Sci Rep       Date:  2022-09-28       Impact factor: 4.996

6.  Mammographic density as a predictor of breast cancer survival: the Multiethnic Cohort.

Authors:  Gertraud Maskarinec; Ian S Pagano; Melissa A Little; Shannon M Conroy; Song-Yi Park; Laurence N Kolonel
Journal:  Breast Cancer Res       Date:  2013-01-22       Impact factor: 6.466

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.